Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
China
· Delayed Price · Currency is CNY 23.78
-0.04 (-0.17%)
Apr 30, 2025, 3:04 PM CST
SHE:002287 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 2,376 | 2,338 | 2,040 | 2,040 | 1,766 | 1,480 | Upgrade
|
| Other Revenue | - | - | 5.55 | 4.63 | 4.06 | 4.58 | Upgrade
|
| Revenue | 2,376 | 2,338 | 2,045 | 2,045 | 1,770 | 1,485 | Upgrade
|
| Revenue Growth (YoY) | 12.37% | 14.32% | 0.02% | 15.49% | 19.22% | 5.87% | Upgrade
|
| Cost of Revenue | 6.43 | 418.37 | 324.7 | 325.52 | 269.7 | 217.36 | Upgrade
|
| Gross Profit | 2,369 | 1,920 | 1,720 | 1,719 | 1,501 | 1,268 | Upgrade
|
| Selling, General & Admin | 13.66 | 1,280 | 1,162 | 1,107 | 986.35 | 828.33 | Upgrade
|
| Research & Development | -0.55 | 66.73 | 58.63 | 55.09 | 70.82 | 60.32 | Upgrade
|
| Other Operating Expenses | 1,697 | -38.87 | 32.26 | 29.47 | 28.58 | 25.68 | Upgrade
|
| Operating Expenses | 1,711 | 1,308 | 1,253 | 1,192 | 1,084 | 915.16 | Upgrade
|
| Operating Income | 658.67 | 611.68 | 467.52 | 527.71 | 416.45 | 352.54 | Upgrade
|
| Interest Expense | -14.65 | - | -63.07 | -56.42 | -53.43 | -22.31 | Upgrade
|
| Interest & Investment Income | 1.06 | - | 41.92 | 16.96 | 340.33 | 58.1 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -0.03 | -0.02 | -0.02 | -0.11 | Upgrade
|
| Other Non Operating Income (Expenses) | -11.33 | -64.57 | -1.16 | -3.56 | -2.46 | -0.98 | Upgrade
|
| EBT Excluding Unusual Items | 633.75 | 547.11 | 445.19 | 484.68 | 700.88 | 387.24 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -15.77 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -12.79 | 100.32 | 37.07 | -37.08 | 20.69 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.32 | 0 | -0.07 | -0.35 | Upgrade
|
| Asset Writedown | 0.88 | -1.18 | -0.3 | -1.22 | -0.35 | -0.04 | Upgrade
|
| Other Unusual Items | -7.18 | - | 162.14 | 72.82 | 82.54 | 58.11 | Upgrade
|
| Pretax Income | 614.67 | 646.24 | 644.41 | 519.2 | 787.91 | 444.96 | Upgrade
|
| Income Tax Expense | 62.79 | 64.87 | 65.24 | 49.56 | 77.09 | 40.78 | Upgrade
|
| Earnings From Continuing Operations | 551.88 | 581.37 | 579.18 | 469.64 | 710.83 | 404.18 | Upgrade
|
| Minority Interest in Earnings | 1.82 | 0.91 | 2.02 | 2.9 | 5.05 | -0.22 | Upgrade
|
| Net Income | 553.7 | 582.28 | 581.2 | 472.54 | 715.88 | 403.96 | Upgrade
|
| Net Income to Common | 553.7 | 582.28 | 581.2 | 472.54 | 715.88 | 403.96 | Upgrade
|
| Net Income Growth | -5.50% | 0.19% | 22.99% | -33.99% | 77.21% | 10.90% | Upgrade
|
| Shares Outstanding (Basic) | 530 | 530 | 530 | 530 | 529 | 529 | Upgrade
|
| Shares Outstanding (Diluted) | 530 | 530 | 530 | 530 | 529 | 529 | Upgrade
|
| Shares Change (YoY) | 0.03% | 0.03% | -0.05% | 0.21% | 0.12% | 0.03% | Upgrade
|
| EPS (Basic) | 1.04 | 1.10 | 1.10 | 0.89 | 1.35 | 0.76 | Upgrade
|
| EPS (Diluted) | 1.04 | 1.10 | 1.10 | 0.89 | 1.35 | 0.76 | Upgrade
|
| EPS Growth | -5.52% | 0.15% | 23.05% | -34.13% | 77.01% | 10.87% | Upgrade
|
| Free Cash Flow | - | 201.31 | 458.59 | 13.29 | 909.35 | -101.7 | Upgrade
|
| Free Cash Flow Per Share | - | 0.38 | 0.86 | 0.03 | 1.72 | -0.19 | Upgrade
|
| Dividend Per Share | - | - | 0.480 | 0.390 | 0.590 | 0.340 | Upgrade
|
| Dividend Growth | - | - | 23.08% | -33.90% | 73.53% | -2.86% | Upgrade
|
| Gross Margin | 99.73% | 82.10% | 84.12% | 84.08% | 84.77% | 85.36% | Upgrade
|
| Operating Margin | 27.72% | 26.16% | 22.86% | 25.81% | 23.52% | 23.74% | Upgrade
|
| Profit Margin | 23.31% | 24.91% | 28.42% | 23.11% | 40.43% | 27.20% | Upgrade
|
| Free Cash Flow Margin | - | 8.61% | 22.42% | 0.65% | 51.36% | -6.85% | Upgrade
|
| EBITDA | - | 739.91 | 550.09 | 604.13 | 476.77 | 396.33 | Upgrade
|
| EBITDA Margin | - | 31.65% | 26.90% | 29.54% | 26.93% | 26.69% | Upgrade
|
| D&A For EBITDA | - | 128.23 | 82.57 | 76.42 | 60.32 | 43.79 | Upgrade
|
| EBIT | 658.67 | 611.68 | 467.52 | 527.71 | 416.45 | 352.54 | Upgrade
|
| EBIT Margin | 27.72% | 26.16% | 22.86% | 25.81% | 23.52% | 23.74% | Upgrade
|
| Effective Tax Rate | 10.21% | 10.04% | 10.12% | 9.54% | 9.78% | 9.17% | Upgrade
|
| Revenue as Reported | 37.92 | - | 2,045 | 2,045 | 1,770 | 1,485 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.